Investing Profile

Aaron Royston

InvestorVC

Managing Partner at venBio Partners

venbio.com/aaron.htmlSan Francisco Bay Area

Your Intro Paths to Aaron Royston

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Aaron Royston on

Current Investing Position

venBio Managing Partner

Investment Range

$20.0M - $30.0M

Sweet Spot

$25.0M

Investments On Record

Aaron Royston is on these Sector & Stage Rankings

Aaron Royston's Investments On Record (11)

Company	StageDateRound Size	Total Raised
Attovia Therapeutics	Series CApr 2025$90M Series BMay 2024$110M Series AJun 2023$60M	$260M
Co-investors: James N. Topper (Frazier Healthcare Partners)
Marea Therapeutics	Series BJun 2024$190M	$260M
Co-investors: Jeffrey Tong (Third Rock Ventures), Charles Homcy (Third Rock Ventures), Maha Katabi (Sofinnova Investments), Chris Garabedian (Perceptive Advisors)
Ceptur Therapeutics	Series AJan 2022$75M	$75M
Ablaze Pharmaceuticals	Series ANov 2021$75M	$75M
Co-investors: Hongbo Lu (Vivo Capital)
HistoWiz	Series AOct 2021$32M	$32M
Co-investors: Nathan Dau (Vivo Capital), Evan Cheng
INBRACE	Series DSep 2021$100M Series COct 2019$45M	$150M
Co-investors: Peter Moldt (Novo Ventures), Joseph Siletto (Vivo Capital)
Neurogastrx	Series BAug 2021$60M Series AJan 2018$45M	$110M
Co-investors: Klaus Veitinger (OrbiMed), David Allison (Westlake Village BioPartners)
RayzeBio	Series CJun 2021$110M Series BDec 2020$110M Series AOct 2020$45M	$420M
Co-investors: Jerel Davis (Versant Ventures), Bong Koh (Venrock), bong koh (KohFounders), Maha Katabi (Sofinnova Investments)